These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7635014)

  • 1. Rational use of NSAIDs for musculoskeletal disorders.
    Drug Ther Bull; 1994 Dec; 32(12):91-5. PubMed ID: 7635014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating musculoskeletal disease with NSAIDs. Practitioner's guide.
    Bellamy N
    Can Fam Physician; 1996 Mar; 42():482-6, 489-92. PubMed ID: 8616288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-steroidal anti-inflammatory drugs for relieving pain in musculoskeletal disorders].
    Sütő G
    Orv Hetil; 2019 Jun; 160(22):855-860. PubMed ID: 31131611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical NSAID therapy for musculoskeletal pain.
    Haroutiunian S; Drennan DA; Lipman AG
    Pain Med; 2010 Apr; 11(4):535-49. PubMed ID: 20210866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of inflammatory musculoskeletal disorders.
    White S
    Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):209-22. PubMed ID: 1946548
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol for acute musculoskeletal injuries: physiotherapists' understanding of which is safer, more effective, and when to initiate treatment.
    Braund R; Abbott JH
    Physiother Theory Pract; 2011 Oct; 27(7):482-91. PubMed ID: 21548816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical NSAIDs significantly reduces pain in adults with acute musculoskeletal injuries.
    Vuurberg G; Kerkhoffs GM
    Evid Based Med; 2016 Oct; 21(5):187-8. PubMed ID: 27519814
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of NSAIDs and COX-2 inhibitors in children with musculoskeletal disorders.
    Fahey SM; Silver RM
    J Pediatr Orthop; 2003; 23(6):794-9. PubMed ID: 14581786
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
    Austin MS; Abdul-Hadi O; Parvizi J; Viscusi ER; Einhorn T
    Instr Course Lect; 2009; 58():759-68. PubMed ID: 19385584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical costs of chronic musculoskeletal pain in Italy.
    Garattini L; Koleva D; Motterlini N; Cornago D
    Clin Drug Investig; 2007; 27(2):139-48. PubMed ID: 17217319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.
    Tannenbaum H; Davis P; Russell AS; Atkinson MH; Maksymowych W; Huang SH; Bell M; Hawker GA; Juby A; Vanner S; Sibley J
    CMAJ; 1996 Jul; 155(1):77-88. PubMed ID: 8673987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and benefits of nonsteroidal anti-inflammatory drugs.
    Brooks P
    Am J Med; 1998 Mar; 104(3A):9S-13S; discussion 21S-22S. PubMed ID: 9572315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF; Buchanan WW
    Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and emerging treatments for mild/moderate acute ambulatory pain.
    Weaver AL
    Am J Ther; 2008; 15 Suppl 10():S12-6. PubMed ID: 19127123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nurse-delivered advice intervention can reduce chronic non-steroidal anti-inflammatory drug use in general practice: a randomized controlled trial.
    Jones AC; Coulson L; Muir K; Tolley K; Lophatananon A; Everitt L; Pringle M; Doherty M
    Rheumatology (Oxford); 2002 Jan; 41(1):14-21. PubMed ID: 11792874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Quebec, Canada.
    Rahme E; Toubouti Y; Hunsche E
    Rheumatology (Oxford); 2006 Jul; 45(7):903-10. PubMed ID: 16461440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases.
    Dejaco C; Duftner C; Schirmer M
    Rheumatol Int; 2007 Feb; 27(4):351-5. PubMed ID: 16957886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs. Are there any differences?
    Kaplan B; Swain RA
    Arch Fam Med; 1993 Nov; 2(11):1167-74. PubMed ID: 8124492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Musculoskeletal disorders. Non-steroidal anti-inflammatory drugs.
    Gøtzsche PC
    Clin Evid; 2004 Dec; (12):1702-10. PubMed ID: 15865742
    [No Abstract]   [Full Text] [Related]  

  • 20. Phytodolor® in musculoskeletal disorders: re-analysis and meta-analysis.
    Uehleke B; Brignoli R; Rostock M; Saller R; Melzer J
    Forsch Komplementmed; 2011; 18(5):249-56. PubMed ID: 22105037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.